| LLY | Eli Lilly and Company | $755.68B |
| NVO | Novo Nordisk A/S | $498.39B |
| JNJ | Johnson & Johnson | $353.05B |
| ABBV | AbbVie Inc. | $308.14B |
| MRK | Merck & Co., Inc. | $252.33B |
| AZN | AstraZeneca PLC | $208.30B |
| NVS | Novartis AG | $202.71B |
| ABT | Abbott Laboratories | $197.97B |
| AMGN | Amgen Inc. | $148.22B |
| PFE | Pfizer Inc. | $142.98B |
| SNY | Sanofi | $121.62B |
| VRTX | Vertex Pharmaceuticals Incorporated | $120.84B |
| GILD | Gilead Sciences, Inc. | $115.08B |
| BMY | Bristol-Myers Squibb Company | $114.90B |
| MDT | Medtronic plc | $106.33B |
| REGN | Regeneron Pharmaceuticals, Inc. | $85.55B |
| ZTS | Zoetis Inc. | $79.93B |
| MCK | McKesson Corporation | $73.21B |
| GSK | GSK plc | $71.40B |
| COR | Cencora, Inc. | $44.82B |
| TAK | Takeda Pharmaceutical Company Limited | $42.55B |
| IQV | IQVIA Holdings Inc. | $36.49B |
| IDXX | IDEXX Laboratories, Inc. | $36.42B |
| ARGX | argenx SE | $36.10B |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.75B |
| CAH | Cardinal Health, Inc. | $28.42B |
| BNTX | BioNTech SE | $27.78B |
| BIIB | Biogen Inc. | $22.78B |
| BGNE | BeiGene, Ltd. | $19.99B |
| TEVA | Teva Pharmaceutical Industries Limited | $19.77B |
| ICLR | ICON Public Limited Company | $17.82B |
| UTHR | United Therapeutics Corporation | $16.17B |
| MRNA | Moderna, Inc. | $15.97B |
| RPRX | Royalty Pharma plc | $15.08B |
| VTRS | Viatris Inc. | $14.93B |
| GMAB | Genmab A/S | $14.42B |
| FMS | Fresenius Medical Care AG | $14.01B |
| INCY | Incyte Corporation | $13.96B |
| SMMT | Summit Therapeutics Inc. | $13.25B |
| NBIX | Neurocrine Biosciences, Inc. | $13.06B |
| INSM | Insmed Incorporated | $12.99B |
| DVA | DaVita Inc. | $12.75B |
| BMRN | BioMarin Pharmaceutical Inc. | $12.66B |
| TECH | Bio-Techne Corporation | $12.25B |
| SRPT | Sarepta Therapeutics, Inc. | $12.10B |
| RDY | Dr. Reddy's Laboratories Limited | $12.07B |
| CTLT | Catalent, Inc. | $11.48B |
| PCVX | Vaxcyte, Inc. | $11.27B |
| MEDP | Medpace Holdings, Inc. | $10.63B |
| QGEN | Qiagen N.V. | $10.53B |
| EXEL | Exelixis, Inc. | $10.06B |
| CRL | Charles River Laboratories International, Inc. | $9.90B |
| MASI | Masimo Corporation | $9.35B |
| ITCI | Intra-Cellular Therapies, Inc. | $8.81B |
| ROIV | Roivant Sciences Ltd. | $8.80B |
| RGEN | Repligen Corporation | $8.51B |
| RVMD | Revolution Medicines, Inc. | $7.96B |
| ASND | Ascendis Pharma A/S | $7.34B |
| JAZZ | Jazz Pharmaceuticals plc | $7.26B |
| LEGN | Legend Biotech Corporation | $6.89B |
| MDGL | Madrigal Pharmaceuticals, Inc. | $6.82B |
| NUVL | Nuvalent, Inc. | $6.61B |
| LNTH | Lantheus Holdings, Inc. | $6.33B |
| HALO | Halozyme Therapeutics, Inc. | $6.24B |
| ELAN | Elanco Animal Health Incorporated | $6.19B |
| CORT | Corcept Therapeutics Incorporated | $6.16B |
| BPMC | Blueprint Medicines Corporation | $6.06B |
| IONS | Ionis Pharmaceuticals, Inc. | $6.04B |
| CYTK | Cytokinetics, Incorporated | $5.97B |
| BBIO | BridgeBio Pharma, Inc. | $5.49B |
| TLX | Telix Pharmaceuticals Limited | $5.46B |
| KRYS | Krystal Biotech, Inc. | $5.34B |
| VKTX | Viking Therapeutics, Inc. | $5.33B |
| CRNX | Crinetics Pharmaceuticals, Inc. | $5.30B |
| ALKS | Alkermes plc | $4.95B |
| GRFS | Grifols, S.A. | $4.95B |
| TGTX | TG Therapeutics, Inc. | $4.93B |
| AXSM | Axsome Therapeutics, Inc. | $4.79B |
| ITGR | Integer Holdings Corporation | $4.72B |
| ADMA | ADMA Biologics, Inc. | $4.54B |
| RARE | Ultragenyx Pharmaceutical Inc. | $4.53B |
| ACLX | Arcellx, Inc. | $4.45B |
| BHVN | Biohaven Ltd. | $4.33B |
| APLS | Apellis Pharmaceuticals, Inc. | $4.31B |
| RNA | Avidity Biosciences, Inc. | $4.31B |
| IMVT | Immunovant, Inc. | $4.25B |
| SRRK | Scholar Rock Holding Corporation | $4.17B |
| CRSP | CRISPR Therapeutics AG | $4.16B |
| PBH | Prestige Consumer Healthcare Inc. | $4.13B |
| OGN | Organon & Co. | $4.04B |
| PTCT | PTC Therapeutics, Inc. | $3.86B |
| SHC | Sotera Health Company | $3.74B |
| PRGO | Perrigo Company plc | $3.72B |
| RYTM | Rhythm Pharmaceuticals, Inc. | $3.55B |
| DNLI | Denali Therapeutics Inc. | $3.52B |
| ALVO | Alvotech | $3.47B |
| MLTX | MoonLake Immunotherapeutics | $3.44B |
| JANX | Janux Therapeutics, Inc. | $3.27B |
| IBRX | ImmunityBio, Inc. | $3.23B |
| VRNA | Verona Pharma plc | $3.23B |
| XENE | Xenon Pharmaceuticals Inc. | $3.19B |
| PRKS | United Parks & Resorts Inc. | $3.12B |
| SWTX | SpringWorks Therapeutics, Inc. | $3.10B |
| ACAD | ACADIA Pharmaceuticals Inc. | $3.08B |
| TWST | Twist Bioscience Corporation | $3.06B |
| FOLD | Amicus Therapeutics, Inc. | $3.03B |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $2.98B |
| VERA | Vera Therapeutics, Inc. | $2.97B |
| HCM | HUTCHMED (China) Limited | $2.94B |
| MRUS | Merus N.V. | $2.94B |
| KYMR | Kymera Therapeutics, Inc. | $2.92B |
| DYN | Dyne Therapeutics, Inc. | $2.88B |
| NEOG | Neogen Corporation | $2.85B |
| VCEL | Vericel Corporation | $2.84B |
| APGE | Apogee Therapeutics, Inc. | $2.83B |
| EWTX | Edgewise Therapeutics, Inc. | $2.79B |
| BHC | Bausch Health Companies Inc. | $2.79B |
| ZLAB | Zai Lab Limited | $2.76B |
| LIVN | LivaNova PLC | $2.72B |
| KROS | Keros Therapeutics, Inc. | $2.69B |
| CPRX | Catalyst Pharmaceuticals, Inc. | $2.64B |
| AGIO | Agios Pharmaceuticals, Inc. | $2.62B |
| IOVA | Iovance Biotherapeutics, Inc. | $2.62B |
| QDEL | QuidelOrtho Corporation | $2.59B |
| AMRX | Amneal Pharmaceuticals, Inc. | $2.53B |
| BEAM | Beam Therapeutics Inc. | $2.50B |
| PTGX | Protagonist Therapeutics, Inc. | $2.48B |
| NAMS | NewAmsterdam Pharma Company N.V. | $2.42B |
| GERN | Geron Corporation | $2.41B |
| IDYA | IDEAYA Biosciences, Inc. | $2.40B |
| TMDX | TransMedics Group, Inc. | $2.32B |
| WVE | Wave Life Sciences Ltd. | $2.28B |
| CNMD | CONMED Corporation | $2.26B |
| CNTA | Centessa Pharmaceuticals plc | $2.25B |
| LGND | Ligand Pharmaceuticals Incorporated | $2.24B |
| AKRO | Akero Therapeutics, Inc. | $2.14B |
| RXRX | Recursion Pharmaceuticals, Inc. | $2.14B |
| MIRM | Mirum Pharmaceuticals, Inc. | $2.12B |
| AMPH | Amphastar Pharmaceuticals, Inc. | $2.10B |
| SLNO | Soleno Therapeutics, Inc. | $2.04B |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.03B |
| IRON | Disc Medicine, Inc. | $2.01B |
| GPCR | Structure Therapeutics Inc. | $1.99B |
| TARS | Tarsus Pharmaceuticals, Inc. | $1.94B |
| BLTE | Belite Bio, Inc | $1.89B |
| HRMY | Harmony Biosciences Holdings, Inc. | $1.87B |
| MNKD | MannKind Corporation | $1.84B |
| GLPG | Galapagos NV | $1.79B |
| XNCR | Xencor, Inc. | $1.77B |
| CLDX | Celldex Therapeutics, Inc. | $1.76B |
| ARVN | Arvinas, Inc. | $1.69B |
| DVAX | Dynavax Technologies Corporation | $1.69B |
| NMRA | Neumora Therapeutics, Inc. | $1.68B |
| EVO | Evotec SE | $1.65B |
| RCUS | Arcus Biosciences, Inc. | $1.64B |
| BCRX | BioCryst Pharmaceuticals, Inc. | $1.64B |
| SDGR | Schrödinger, Inc. | $1.61B |
| NRIX | Nurix Therapeutics, Inc. | $1.56B |
| INMD | InMode Ltd. | $1.56B |
| KNSA | Kiniksa Pharmaceuticals International, plc | $1.55B |
| ARQT | Arcutis Biotherapeutics, Inc. | $1.54B |
| IMCR | Immunocore Holdings plc | $1.53B |
| INDV | Indivior PLC | $1.52B |
| NTLA | Intellia Therapeutics, Inc. | $1.50B |
| MRVI | Maravai LifeSciences Holdings, Inc. | $1.50B |
| AUPH | Aurinia Pharmaceuticals Inc. | $1.49B |
| OCUL | Ocular Therapeutix, Inc. | $1.48B |
| TVTX | Travere Therapeutics, Inc. | $1.46B |
| BCYC | Bicycle Therapeutics plc | $1.44B |
| MDXG | MiMedx Group, Inc. | $1.43B |
| NVAX | Novavax, Inc. | $1.40B |
| MYGN | Myriad Genetics, Inc. | $1.40B |
| SYRE | Spyre Therapeutics, Inc. | $1.36B |
| HROW | Harrow, Inc. | $1.35B |
| PGNY | Progyny, Inc. | $1.34B |
| DAWN | Day One Biopharmaceuticals, Inc. | $1.33B |
| PRAX | Praxis Precision Medicines, Inc. | $1.30B |
| MESO | Mesoblast Limited | $1.28B |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.28B |
| SPRY | ARS Pharmaceuticals, Inc. | $1.26B |
| ARDX | Ardelyx, Inc. | $1.25B |
| ANIP | ANI Pharmaceuticals, Inc. | $1.24B |
| RCKT | Rocket Pharmaceuticals, Inc. | $1.23B |
| BLFS | BioLife Solutions, Inc. | $1.22B |
| INVA | Innoviva, Inc. | $1.19B |
| ELVN | Enliven Therapeutics, Inc. | $1.16B |
| UPB | Upstream Bio, Inc. | $1.13B |
| VIR | Vir Biotechnology, Inc. | $1.11B |
| OPK | OPKO Health, Inc. | $1.06B |
| CBLL | CeriBell, Inc. | $1.06B |
| BCAX | Bicara Therapeutics Inc. | $1.05B |
| COGT | Cogent Biosciences, Inc. | $1.05B |
| GYRE | Gyre Therapeutics, Inc. | $1.03B |
| SEPN | Septerna, Inc. | $1.02B |
| ADPT | Adaptive Biotechnologies Corporation | $990.26M |
| AVDL | Avadel Pharmaceuticals plc | $963.62M |
| PHVS | Pharvaris N.V. | $956.91M |
| AVBP | ArriVent BioPharma, Inc. | $954.64M |
| PAHC | Phibro Animal Health Corporation | $936.04M |
| LENZ | LENZ Therapeutics, Inc. | $933.93M |
| PSTX | Poseida Therapeutics, Inc. | $921.04M |
| PCRX | Pacira BioSciences, Inc. | $912.38M |
| LQDA | Liquidia Corporation | $909.84M |
| NUVB | Nuvation Bio Inc. | $902.00M |
| ZYME | Zymeworks Inc. | $899.54M |
| ABCL | AbCellera Biologics Inc. | $889.89M |
| PLRX | Pliant Therapeutics, Inc. | $883.59M |
| REPL | Replimune Group, Inc. | $878.48M |
| IMNM | Immunome, Inc. | $867.59M |
| ETNB | 89bio, Inc. | $849.01M |
| ERAS | Erasca, Inc. | $836.87M |
| ORKA | Oruka Therapeutics, Inc. | $834.72M |
| TYRA | Tyra Biosciences, Inc. | $821.29M |
| AGL | agilon health, inc. | $819.92M |
| KURA | Kura Oncology, Inc. | $800.19M |
| CDMO | Avid Bioservices, Inc. | $785.32M |
| PRTA | Prothena Corporation plc | $782.92M |
| IMTX | Immatics N.V. | $778.48M |
| HLF | Herbalife Ltd. | $772.07M |
| TRDA | Entrada Therapeutics, Inc. | $767.48M |
| AUTL | Autolus Therapeutics plc | $763.77M |
| EOLS | Evolus, Inc. | $762.39M |
| RAPP | Rapport Therapeutics, Inc. | $749.82M |
| QURE | uniQure N.V. | $745.77M |
| RLAY | Relay Therapeutics, Inc. | $741.51M |
| DNTH | Dianthus Therapeutics, Inc. | $734.30M |
| CGEM | Cullinan Therapeutics, Inc. | $730.76M |
| MBX | MBX Biosciences, Inc. | $723.49M |
| CVAC | CureVac N.V. | $719.00M |
| TECX | Tectonic Therapeutic, Inc. | $714.92M |
| ABUS | Arbutus Biopharma Corporation | $712.49M |
| AVXL | Anavex Life Sciences Corp. | $710.59M |
| ANAB | AnaptysBio, Inc. | $702.60M |
| STOK | Stoke Therapeutics, Inc. | $702.34M |
| OCS | Oculis Holding AG | $682.61M |
| CAPR | Capricor Therapeutics, Inc. | $676.14M |
| COLL | Collegium Pharmaceutical, Inc. | $672.35M |
| MLYS | Mineralys Therapeutics, Inc. | $653.96M |
| AXGN | Axogen, Inc. | $653.08M |
| TRML | Tourmaline Bio, Inc. | $641.07M |
| ALT | Altimmune, Inc. | $640.83M |
| ORIC | ORIC Pharmaceuticals, Inc. | $636.51M |
| DNA | Ginkgo Bioworks Holdings, Inc. | $615.02M |
| OMER | Omeros Corporation | $610.79M |
| PHAT | Phathom Pharmaceuticals, Inc. | $610.61M |
| ESPR | Esperion Therapeutics, Inc. | $598.99M |
| MREO | Mereo BioPharma Group plc | $598.86M |
| IRWD | Ironwood Pharmaceuticals, Inc. | $595.31M |
| PROK | ProKidney Corp. | $594.99M |
| TERN | Terns Pharmaceuticals, Inc. | $587.78M |
| PHAR | Pharming Group N.V. | $586.52M |
| GLUE | Monte Rosa Therapeutics, Inc. | $579.96M |
| RNAC | Cartesian Therapeutics, Inc. | $579.71M |
| SVRA | Savara Inc. | $576.64M |
| ATXS | Astria Therapeutics, Inc. | $573.37M |
| VERV | Verve Therapeutics, Inc. | $568.94M |
| THRD | Third Harmonic Bio, Inc. | $567.29M |
| IGMS | IGM Biosciences, Inc. | $564.32M |
| CRMD | CorMedix Inc. | $557.02M |
| OPT | Opthea Limited | $555.07M |
| SANA | Sana Biotechnology, Inc. | $553.71M |
| OLMA | Olema Pharmaceuticals, Inc. | $552.35M |
| PRTC | PureTech Health plc | $540.01M |
| ABVX | ABIVAX Société Anonyme | $539.83M |
| HUMA | Humacyte, Inc. | $536.16M |
| XERS | Xeris Biopharma Holdings, Inc. | $533.71M |
| KOD | Kodiak Sciences Inc. | $526.24M |
| ANNX | Annexon, Inc. | $519.11M |
| TSHA | Taysha Gene Therapies, Inc. | $516.46M |
| CRVS | Corvus Pharmaceuticals, Inc. | $515.34M |
| URGN | UroGen Pharma Ltd. | $508.08M |
| ARCT | Arcturus Therapeutics Holdings Inc. | $497.32M |
| TBPH | Theravance Biopharma, Inc. | $495.68M |
| OABI | OmniAb, Inc. | $491.31M |
| MGTX | MeiraGTx Holdings plc | $489.24M |
| ORGO | Organogenesis Holdings Inc. | $487.88M |
| RGNX | REGENXBIO Inc. | $483.56M |
| ZVRA | Zevra Therapeutics, Inc. | $475.05M |
| GHRS | GH Research PLC | $466.69M |
| KALV | KalVista Pharmaceuticals, Inc. | $466.51M |
| EBS | Emergent BioSolutions Inc. | $464.36M |
| SIGA | SIGA Technologies, Inc. | $461.99M |
| ABSI | Absci Corporation | $461.72M |
| YMAB | Y-mAbs Therapeutics, Inc. | $460.43M |
| ALLO | Allogene Therapeutics, Inc. | $459.18M |
| ALMS | Alumis Inc. | $456.48M |
| NRC | National Research Corporation | $454.26M |
| AURA | Aura Biosciences, Inc. | $445.07M |
| KRRO | Korro Bio, Inc. | $437.97M |
| SMLR | Semler Scientific, Inc. | $434.74M |
| MXCT | MaxCyte, Inc. | $433.68M |
| AKBA | Akebia Therapeutics, Inc. | $432.00M |
| TKNO | Alpha Teknova, Inc. | $425.93M |
| PRME | Prime Medicine, Inc. | $422.34M |
| LRMR | Larimar Therapeutics, Inc. | $419.21M |
| CYRX | Cryoport, Inc. | $410.27M |
| SLRN | Acelyrin, Inc. | $407.32M |
| SGMO | Sangamo Therapeutics, Inc. | $406.86M |
| ZBIO | Zenas BioPharma, Inc. | $397.01M |
| DSGN | Design Therapeutics, Inc. | $374.83M |
| CTNM | Contineum Therapeutics, Inc. | $371.72M |
| NUS | Nu Skin Enterprises, Inc. | $370.84M |
| RIGL | Rigel Pharmaceuticals, Inc. | $362.17M |
| TNGX | Tango Therapeutics, Inc. | $355.55M |
| NGNE | Neurogene Inc. | $352.06M |
| ENGN | enGene Holdings Inc. | $350.19M |
| AQST | Aquestive Therapeutics, Inc. | $348.30M |
| FHTX | Foghorn Therapeutics Inc. | $348.01M |
| XOMA | XOMA Royalty Corporation | $347.47M |
| SLN | Silence Therapeutics plc | $346.32M |
| VMD | Viemed Healthcare, Inc. | $341.67M |
| SAGE | Sage Therapeutics, Inc. | $340.74M |
| VYGR | Voyager Therapeutics, Inc. | $338.13M |
| FDMT | 4D Molecular Therapeutics, Inc. | $334.69M |
| JSPR | Jasper Therapeutics, Inc. | $334.68M |
| RVNC | Revance Therapeutics, Inc. | $317.33M |
| ALDX | Aldeyra Therapeutics, Inc. | $315.02M |
| JUNS | Jupiter Neurosciences, Inc. | $312.33M |
| ACIU | AC Immune SA | $311.48M |
| ETON | Eton Pharmaceuticals, Inc. | $311.07M |
| CMPS | COMPASS Pathways plc | $310.49M |
| AMLX | Amylyx Pharmaceuticals, Inc. | $309.15M |
| IMMP | Immutep Limited | $308.37M |
| MRSN | Mersana Therapeutics, Inc. | $306.36M |
| CCCC | C4 Therapeutics, Inc. | $304.24M |
| NATR | Nature's Sunshine Products, Inc. | $300.78M |
| ITOS | iTeos Therapeutics, Inc. | $300.67M |
| ARTV | Artiva Biotherapeutics, Inc. | $298.52M |
| QTTB | Q32 Bio Inc. | $297.33M |
| VALN | Valneva SE | $293.45M |
| ELDN | Eledon Pharmaceuticals, Inc. | $288.54M |
| RZLT | Rezolute, Inc. | $286.82M |
| TNYA | Tenaya Therapeutics, Inc. | $283.61M |
| LXEO | Lexeo Therapeutics, Inc. | $276.43M |
| ATYR | aTyr Pharma, Inc. | $276.17M |
| PROC | Procaps Group S.A. | $273.03M |
| BNTC | Benitec Biopharma Inc. | $272.56M |
| KMDA | Kamada Ltd. | $272.18M |
| PRQR | ProQR Therapeutics N.V. | $269.28M |
| VNDA | Vanda Pharmaceuticals Inc. | $268.22M |
| HRTX | Heron Therapeutics, Inc. | $267.69M |
| ZYXI | Zynex, Inc. | $267.50M |
| LXRX | Lexicon Pharmaceuticals, Inc. | $264.58M |
| RENB | Renovaro Inc. | $260.30M |
| ABEO | Abeona Therapeutics Inc. | $259.96M |
| FATE | Fate Therapeutics, Inc. | $259.68M |
| DRUG | Bright Minds Biosciences Inc. | $259.60M |
| ACRS | Aclaris Therapeutics, Inc. | $259.29M |
| OCGN | Ocugen, Inc. | $257.29M |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $257.27M |
| ATAI | Atai Life Sciences N.V. | $256.74M |
| LYEL | Lyell Immunopharma, Inc. | $255.54M |
| HURA | TuHURA Biosciences, Inc. | $250.75M |
| AVIR | Atea Pharmaceuticals, Inc. | $248.32M |
| CMRX | Chimerix, Inc. | $248.22M |
| CMPX | Compass Therapeutics, Inc. | $244.91M |
| PGEN | Precigen, Inc. | $228.76M |
| LFCR | Lifecore Biomedical, Inc. | $224.94M |
| VSTM | Verastem, Inc. | $222.53M |
| SOPH | SOPHiA GENETICS SA | $221.78M |
| DMAC | DiaMedica Therapeutics Inc. | $220.64M |
| FULC | Fulcrum Therapeutics, Inc. | $218.45M |
| INBX | Inhibrx Biosciences, Inc. | $216.70M |
| ALEC | Alector, Inc. | $216.43M |
| IKT | Inhibikase Therapeutics, Inc. | $215.02M |
| ADCT | ADC Therapeutics SA | $214.65M |
| ACRV | Acrivon Therapeutics, Inc. | $213.59M |
| MGNX | MacroGenics, Inc. | $209.63M |
| BMEA | Biomea Fusion, Inc. | $208.73M |
| CLYM | Climb Bio, Inc. | $207.05M |
| TRVI | Trevi Therapeutics, Inc. | $206.00M |
| MOLN | Molecular Partners AG | $204.67M |
| TSVT | 2seventy bio, Inc. | $203.77M |
| XBIT | XBiotech Inc. | $202.11M |
| SLDB | Solid Biosciences Inc. | $201.77M |
| KYTX | Kyverna Therapeutics, Inc. | $198.16M |
| VTYX | Ventyx Biosciences, Inc. | $196.58M |
| GNFT | Genfit S.A. | $196.35M |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $195.36M |
| CLLS | Cellectis S.A. | $194.17M |
| STRO | Sutro Biopharma, Inc. | $193.78M |
| CRDF | Cardiff Oncology, Inc. | $193.29M |
| CKPT | Checkpoint Therapeutics, Inc. | $191.91M |
| AMRN | Amarin Corporation plc | $191.68M |
| INZY | Inozyme Pharma, Inc. | $191.44M |
| NKTR | Nektar Therapeutics | $188.15M |
| CHRS | Coherus BioSciences, Inc. | $185.49M |
| CRBU | Caribou Biosciences, Inc. | $183.82M |
| OKUR | OnKure Therapeutics, Inc. | $183.15M |
| ENTA | Enanta Pharmaceuticals, Inc. | $183.12M |
| LFVN | LifeVantage Corporation | $182.87M |
| ZURA | Zura Bio Limited | $181.52M |
| SCPH | scPharmaceuticals Inc. | $180.64M |
| TCRX | TScan Therapeutics, Inc. | $177.72M |
| NKTX | Nkarta, Inc. | $175.72M |
| TVGN | Tevogen Bio Holdings Inc. | $174.63M |
| GLSI | Greenwich LifeSciences, Inc. | $174.43M |
| EDIT | Editas Medicine, Inc. | $173.35M |
| PEPG | PepGen Inc. | $168.19M |
| FENC | Fennec Pharmaceuticals Inc. | $167.80M |
| GOSS | Gossamer Bio, Inc. | $167.44M |
| TELO | Telomir Pharmaceuticals, Inc. | $165.22M |
| ACTU | Actuate Therapeutics, Inc. | $163.68M |
| TIL | Instil Bio, Inc. | $163.08M |
| BIOA | BioAge Labs, Inc. | $160.24M |
| OGI | Organigram Holdings Inc. | $159.85M |
| MCRB | Seres Therapeutics, Inc. | $159.44M |
| ADAP | Adaptimmune Therapeutics plc | $159.39M |
| ATOS | Atossa Therapeutics, Inc. | $158.51M |
| MGX | Metagenomi, Inc. | $156.81M |
| CDTX | Cidara Therapeutics, Inc. | $156.22M |
| NBTX | Nanobiotix S.A. | $155.07M |
| ACHV | Achieve Life Sciences, Inc. | $150.63M |
| SGMT | Sagimet Biosciences Inc. | $150.00M |
| CADL | Candel Therapeutics, Inc. | $149.71M |
| ELUT | Elutia Inc. | $148.27M |
| PBYI | Puma Biotechnology, Inc. | $148.24M |
| IFRX | InflaRx N.V. | $147.21M |
| IPHA | Innate Pharma S.A. | $144.82M |
| VXRT | Vaxart, Inc. | $142.24M |
| CGEN | Compugen Ltd. | $141.19M |
| APLT | Applied Therapeutics, Inc. | $140.79M |
| CABA | Cabaletta Bio, Inc. | $140.03M |
| SAVA | Cassava Sciences, Inc. | $139.04M |
| BDTX | Black Diamond Therapeutics, Inc. | $138.07M |
| IVA | Inventiva S.A. | $134.98M |
| ABOS | Acumen Pharmaceuticals, Inc. | $130.37M |
| TARA | Protara Therapeutics, Inc. | $128.94M |
| RPTX | Repare Therapeutics Inc. | $127.96M |
| NOTV | Inotiv, Inc. | $125.91M |
| ADVM | Adverum Biotechnologies, Inc. | $122.53M |
| QIPT | Quipt Home Medical Corp. | $121.51M |
| GALT | Galectin Therapeutics Inc. | $121.13M |
| LPTX | Leap Therapeutics, Inc. | $121.08M |
| MNPR | Monopar Therapeutics Inc. | $120.65M |
| INMB | INmune Bio, Inc. | $120.62M |
| IPSC | Century Therapeutics, Inc. | $119.89M |
| CRDL | Cardiol Therapeutics Inc. | $118.32M |
| CNTX | Context Therapeutics Inc. | $117.00M |
| EPRX | Eupraxia Pharmaceuticals Inc. | $116.49M |
| XFOR | X4 Pharmaceuticals, Inc. | $114.85M |
| DERM | Journey Medical Corporation | $113.64M |
| IMUX | Immunic, Inc. | $111.70M |
| ADAG | Adagene Inc. | $111.62M |
| MNOV | MediciNova, Inc. | $110.84M |
| SKYE | Skye Bioscience, Inc. | $110.73M |
| ALGS | Aligos Therapeutics, Inc. | $110.58M |
| SCLX | Scilex Holding Company | $110.22M |
| RANI | Rani Therapeutics Holdings, Inc. | $108.85M |
| RGLS | Regulus Therapeutics Inc. | $107.42M |
| FONR | FONAR Corporation | $107.02M |
| VERU | Veru Inc. | $105.43M |
| ANRO | Alto Neuroscience, Inc. | $104.91M |
| ASMB | Assembly Biosciences, Inc. | $102.40M |
| COYA | Coya Therapeutics, Inc. | $102.25M |
| TLSA | Tiziana Life Sciences Ltd | $101.35M |
| ORMP | Oramed Pharmaceuticals Inc. | $101.18M |
| MIST | Milestone Pharmaceuticals Inc. | $101.06M |
| AVTX | Avalo Therapeutics, Inc. | $100.72M |
| PYXS | Pyxis Oncology, Inc. | $99.90M |
| ME | 23andMe Holding Co. | $99.25M |
| HLVX | HilleVax, Inc. | $98.12M |
| ALLK | Allakos Inc. | $96.49M |
| NVCT | Nuvectis Pharma, Inc. | $95.64M |
| CTMX | CytomX Therapeutics, Inc. | $94.69M |
| ANIX | Anixa Biosciences, Inc. | $94.61M |
| GNTA | Genenta Science S.p.A. | $94.18M |
| GNLX | Genelux Corporation | $93.94M |
| VIGL | Vigil Neuroscience, Inc. | $91.98M |
| ABP | Abpro Holdings, Inc. | $91.70M |
| KPTI | Karyopharm Therapeutics Inc. | $91.48M |
| ASRT | Assertio Holdings, Inc. | $91.26M |
| IZTC | Invizyne Technologies, Inc. | $87.66M |
| ACET | Adicet Bio, Inc. | $87.35M |
| ECOR | electroCore, Inc. | $86.91M |
| QNCX | Quince Therapeutics, Inc. | $86.68M |
| IMAB | I-Mab | $85.54M |
| GBIO | Generation Bio Co. | $85.49M |
| EDAP | EDAP TMS S.A. | $84.97M |
| ENTX | Entera Bio Ltd. | $84.35M |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. | $84.27M |
| ALXO | ALX Oncology Holdings Inc. | $83.33M |
| FBLG | FibroBiologics, Inc. | $83.18M |
| HOWL | Werewolf Therapeutics, Inc. | $82.89M |
| UNCY | Unicycive Therapeutics, Inc. | $82.83M |
| PMVP | PMV Pharmaceuticals, Inc. | $82.80M |
| ANVS | Annovis Bio, Inc. | $82.23M |
| IKNA | Ikena Oncology, Inc. | $82.04M |
| BLUE | bluebird bio, Inc. | $81.26M |
| OVID | Ovid Therapeutics Inc. | $80.95M |
| PDSB | PDS Biotechnology Corporation | $80.06M |
| ANL | Adlai Nortye Ltd. | $79.34M |
| AGEN | Agenus Inc. | $78.70M |
| BCAB | BioAtla, Inc. | $77.84M |
| OPTN | OptiNose, Inc. | $76.36M |
| AVTE | Aerovate Therapeutics, Inc. | $75.94M |
| CLSD | Clearside Biomedical, Inc. | $75.84M |
| VANI | Vivani Medical, Inc. | $75.82M |
| EPIX | ESSA Pharma Inc. | $74.98M |
| SLS | SELLAS Life Sciences Group, Inc. | $73.20M |
| HYPR | Hyperfine, Inc. | $72.23M |
| CUE | Cue Biopharma, Inc. | $72.22M |
| IVVD | Invivyd, Inc. | $71.77M |
| CSBR | Champions Oncology, Inc. | $70.82M |
| ATRA | Atara Biotherapeutics, Inc. | $70.18M |
| VTGN | Vistagen Therapeutics, Inc. | $69.89M |
| VOR | Vor Biopharma Inc. | $69.36M |
| BOLD | Boundless Bio, Inc. | $69.13M |
| OM | Outset Medical, Inc. | $67.78M |
| SCNX | Scienture Holdings, Inc. | $67.67M |
| IMRX | Immuneering Corporation | $67.38M |
| RMTI | Rockwell Medical, Inc. | $67.22M |
| BYSI | BeyondSpring Inc. | $67.13M |
| DBVT | DBV Technologies S.A. | $66.59M |
| MURA | Mural Oncology plc | $66.19M |
| ONCY | Oncolytics Biotech Inc. | $66.13M |
| THTX | Theratechnologies Inc. | $64.37M |
| KRON | Kronos Bio, Inc. | $63.36M |
| INCR | InterCure Ltd. | $63.35M |
| ITRM | Iterum Therapeutics plc | $63.29M |
| SPRO | Spero Therapeutics, Inc. | $62.97M |
| CNTB | Connect Biopharma Holdings Limited | $62.82M |
| STTK | Shattuck Labs, Inc. | $62.06M |
| LUNA | Luna Innovations Incorporated | $61.47M |
| BGM | BGM Group Ltd | $60.99M |
| ELTX | Elicio Therapeutics, Inc. | $60.32M |
| IMMX | Immix Biopharma, Inc. | $60.24M |
| ALVR | AlloVir, Inc. | $59.03M |
| AADI | Aadi Bioscience, Inc. | $58.91M |
| PTHL | Pheton Holdings Ltd | $58.58M |
| FBIO | Fortress Biotech, Inc. | $58.52M |
| IOBT | IO Biotech, Inc. | $55.65M |
| OMGA | Omega Therapeutics, Inc. | $55.37M |
| TXMD | TherapeuticsMD, Inc. | $55.08M |
| SNYR | Synergy CHC Corp. | $54.46M |
| PRLD | Prelude Therapeutics Incorporated | $53.38M |
| VTVT | vTv Therapeutics Inc. | $53.27M |
| CASI | CASI Pharmaceuticals, Inc. | $53.03M |
| CLRB | Cellectar Biosciences, Inc. | $52.83M |
| CELU | Celularity Inc. | $52.61M |
| NXL | Nexalin Technology, Inc. | $51.19M |
| KZR | Kezar Life Sciences, Inc. | $50.71M |
| LSB | LakeShore Biopharma Co., Ltd | $49.80M |
| ESLA | Estrella Immunopharma, Inc. | $49.57M |
| RLYB | Rallybio Corporation | $49.37M |
| BIVI | BioVie Inc. | $49.04M |
| PASG | Passage Bio, Inc. | $48.95M |
| SCYX | SCYNEXIS, Inc. | $47.06M |
| DYAI | Dyadic International, Inc. | $47.05M |
| XLO | Xilio Therapeutics, Inc. | $46.82M |
| ALRN | Aileron Therapeutics, Inc. | $46.37M |
| ANTX | AN2 Therapeutics, Inc. | $45.12M |
| GANX | Gain Therapeutics, Inc. | $45.09M |
| DTIL | Precision BioSciences, Inc. | $44.11M |
| ELEV | Elevation Oncology, Inc. | $44.05M |
| CDIO | Cardio Diagnostics Holdings, Inc. | $43.67M |
| ICCC | ImmuCell Corporation | $43.58M |
| ACHL | Achilles Therapeutics plc | $43.14M |
| LTRN | Lantern Pharma Inc. | $42.92M |
| OCX | OncoCyte Corporation | $42.09M |
| GRCE | Grace Therapeutics, Inc. | $41.88M |
| GELS | Gelteq Limited | $41.62M |
| MOVE | Movano Inc. | $40.80M |
| ANEB | Anebulo Pharmaceuticals, Inc. | $40.72M |
| VRCA | Verrica Pharmaceuticals Inc. | $39.92M |
| CLNN | Clene Inc. | $39.34M |
| SABS | SAB Biotherapeutics, Inc. | $39.23M |
| LEXX | Lexaria Bioscience Corp. | $39.21M |
| VYNE | VYNE Therapeutics Inc. | $38.94M |
| BCTX | BriaCell Therapeutics Corp. | $38.71M |
| TPST | Tempest Therapeutics, Inc. | $38.66M |
| LVTX | LAVA Therapeutics N.V. | $38.25M |
| RAPT | RAPT Therapeutics, Inc. | $38.10M |
| OTLK | Outlook Therapeutics, Inc. | $38.09M |
| IRD | Opus Genetics, Inc. | $37.88M |
| BRNS | Barinthus Biotherapeutics plc | $37.81M |
| LUMO | Lumos Pharma, Inc. | $37.54M |
| CALC | CalciMedica, Inc. | $37.08M |
| FGEN | FibroGen, Inc. | $36.77M |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $36.74M |
| OKYO | OKYO Pharma Limited | $36.21M |
| INTS | Intensity Therapeutics, Inc. | $35.63M |
| MRKR | Marker Therapeutics, Inc. | $35.52M |
| AFMD | Affimed N.V. | $35.33M |
| XCUR | Exicure, Inc. | $35.08M |
| FBRX | Forte Biosciences, Inc. | $34.37M |
| CPIX | Cumberland Pharmaceuticals Inc. | $34.26M |
| CRIS | Curis, Inc. | $33.53M |
| POCI | Precision Optics Corporation, Inc. | $33.47M |
| RNXT | RenovoRx, Inc. | $32.88M |
| GDTC | CytoMed Therapeutics Limited | $31.73M |
| NXTC | NextCure, Inc. | $31.65M |
| SRZN | Surrozen, Inc. | $30.45M |
| PMN | ProMIS Neurosciences, Inc. | $30.18M |
| KALA | KALA BIO, Inc. | $29.78M |
| IXHL | Incannex Healthcare Inc. | $29.29M |
| PLUR | Pluri Inc. | $29.18M |
| LGVN | Longeveron Inc. | $29.08M |
| DARE | Daré Bioscience, Inc. | $29.06M |
| HOOK | HOOKIPA Pharma Inc. | $29.05M |
| IRIX | IRIDEX Corporation | $28.95M |
| CARM | Carisma Therapeutics, Inc. | $28.92M |
| LPCN | Lipocine Inc. | $27.81M |
| INKT | MiNK Therapeutics, Inc. | $26.19M |
| ENLV | Enlivex Therapeutics Ltd. | $26.10M |
| SNTI | Senti Biosciences, Inc. | $25.79M |
| ONMD | OneMedNet Corporation | $25.47M |
| CTXR | Citius Pharmaceuticals, Inc. | $25.27M |
| CMMB | Chemomab Therapeutics Ltd. | $25.14M |
| EQ | Equillium, Inc. | $24.84M |
| AKTX | Akari Therapeutics, Plc | $24.76M |
| DRRX | DURECT Corporation | $24.66M |
| ATHA | Athira Pharma, Inc. | $24.04M |
| OCEA | Ocean Biomedical, Inc. | $23.68M |
| LSTA | Lisata Therapeutics, Inc. | $23.63M |
| GOVX | GeoVax Labs, Inc. | $23.12M |
| FLGC | Flora Growth Corp. | $22.59M |
| PIRS | Palvella Therapeutics, Inc. | $22.44M |
| SPRB | Spruce Biosciences, Inc. | $22.18M |
| INAB | IN8bio, Inc. | $22.11M |
| BFRG | Bullfrog AI Holdings, Inc. | $22.04M |
| BOLT | Bolt Biotherapeutics, Inc. | $21.86M |
| PULM | Pulmatrix, Inc. | $21.77M |
| CVKD | Cadrenal Therapeutics, Inc. | $20.97M |
| MIRA | MIRA Pharmaceuticals, Inc. | $20.70M |
| ATHE | Alterity Therapeutics Limited | $20.28M |
| TENX | Tenax Therapeutics, Inc. | $20.25M |
| COCP | Cocrystal Pharma, Inc. | $20.09M |
| NRSN | NeuroSense Therapeutics Ltd. | $19.86M |
| UBX | Unity Biotechnology, Inc. | $19.71M |
| PYPD | PolyPid Ltd. | $19.53M |
| MTVA | MetaVia Inc. | $19.47M |
| BLRX | BioLineRx Ltd. | $19.07M |
| APRE | Aprea Therapeutics, Inc. | $18.95M |
| GLYC | GlycoMimetics, Inc. | $18.89M |
| BTAI | BioXcel Therapeutics, Inc. | $18.78M |
| MEIP | MEI Pharma, Inc. | $18.66M |
| COSM | Cosmos Health Inc. | $18.33M |
| CGTX | Cognition Therapeutics, Inc. | $18.01M |
| CRVO | CervoMed Inc. | $17.83M |
| CYTH | Cyclo Therapeutics, Inc. | $17.81M |
| NKGN | NKGen Biotech, Inc. | $17.47M |
| SYBX | Synlogic, Inc. | $16.96M |
| ERNA | Eterna Therapeutics Inc. | $16.95M |
| MBOT | Microbot Medical Inc. | $16.93M |
| NERV | Minerva Neurosciences, Inc. | $16.36M |
| PRPH | ProPhase Labs, Inc. | $16.11M |
| ACXP | Acurx Pharmaceuticals, Inc. | $15.69M |
| TRAW | Traws Pharma, Inc. | $15.58M |
| HCWB | HCW Biologics Inc. | $15.25M |
| BIAF | bioAffinity Technologies, Inc. | $15.12M |
| MRNS | Marinus Pharmaceuticals, Inc. | $15.11M |
| CARA | Cara Therapeutics, Inc. | $14.95M |
| NRXP | NRx Pharmaceuticals, Inc. | $14.63M |
| SLGL | Sol-Gel Technologies Ltd. | $14.21M |
| RLMD | Relmada Therapeutics, Inc. | $14.18M |
| CING | Cingulate Inc. | $13.91M |
| HWH | HWH International Inc. | $13.76M |
| CERO | CERo Therapeutics Holdings, Inc. | $13.47M |
| IMNN | Imunon, Inc. | $13.04M |
| PMCB | PharmaCyte Biotech, Inc. | $12.44M |
| TLPH | Talphera, Inc. | $12.35M |
| AWH | Aspira Women's Health Inc. | $12.12M |
| MYNZ | Mainz Biomed N.V. | $12.00M |
| KZIA | Kazia Therapeutics Limited | $11.95M |
| SNSE | Sensei Biotherapeutics, Inc. | $11.82M |
| TSBX | Turnstone Biologics Corp. | $11.80M |
| JAGX | Jaguar Health, Inc. | $11.68M |
| IMRN | Immuron Limited | $11.47M |
| CYCN | Cyclerion Therapeutics, Inc. | $11.30M |
| IPA | ImmunoPrecise Antibodies Ltd. | $10.93M |
| KPRX | Kiora Pharmaceuticals, Inc. | $10.92M |
| QTI | QT Imaging Holdings, Inc. | $10.48M |
| DOMH | Dominari Holdings Inc. | $10.42M |
| BCDA | BioCardia, Inc. | $10.41M |
| RDHL | RedHill Biopharma Ltd. | $10.40M |
| VCNX | Vaccinex, Inc. | $10.37M |
| INDP | Indaptus Therapeutics, Inc. | $10.20M |
| AYTU | Aytu BioPharma, Inc. | $10.15M |
| CDT | Conduit Pharmaceuticals Inc. | $9.67M |
| KLTO | Klotho Neurosciences, Inc. | $9.61M |
| XTLB | XTL Biopharmaceuticals Ltd. | $9.26M |
| BFRI | Biofrontera Inc. | $9.22M |
| BCLI | Brainstorm Cell Therapeutics Inc. | $9.18M |
| ENSC | Ensysce Biosciences, Inc. | $8.94M |
| MBIO | Mustang Bio, Inc. | $8.89M |
| STRR | Star Equity Holdings, Inc. | $8.80M |
| GNPX | Genprex, Inc. | $8.76M |
| SNGX | Soligenix, Inc. | $8.68M |
| EYEN | Eyenovia, Inc. | $8.58M |
| ADXN | Addex Therapeutics Ltd | $8.35M |
| GRI | GRI Bio, Inc. | $8.28M |
| APLM | Apollomics, Inc. | $7.90M |
| ELAB | PMGC Holdings Inc. | $7.89M |
| VRAX | Virax Biolabs Group Limited | $7.86M |
| CUTR | Cutera, Inc. | $7.78M |
| ADIL | Adial Pharmaceuticals, Inc. | $7.56M |
| TRIB | Trinity Biotech plc | $7.51M |
| GLTO | Galecto, Inc. | $7.45M |
| COEP | Coeptis Therapeutics Holdings, Inc. | $7.31M |
| VINC | Vincerx Pharma, Inc. | $7.21M |
| EVAX | Evaxion Biotech A/S | $7.20M |
| MBRX | Moleculin Biotech, Inc. | $6.93M |
| OTRK | Ontrak, Inc. | $6.83M |
| GTBP | GT Biopharma, Inc. | $6.80M |
| VIRX | Viracta Therapeutics, Inc. | $6.76M |
| XBIO | Xenetic Biosciences, Inc. | $6.71M |
| SYRS | Syros Pharmaceuticals, Inc. | $6.54M |
| ONVO | Organovo Holdings, Inc. | $6.45M |
| CNSP | CNS Pharmaceuticals, Inc. | $6.28M |
| MGRX | Mangoceuticals, Inc. | $6.19M |
| ABVC | ABVC BioPharma, Inc. | $6.16M |
| AIMD | Ainos, Inc. | $6.14M |
| EDSA | Edesa Biotech, Inc. | $6.11M |
| EVOK | Evoke Pharma, Inc. | $6.06M |
| HOTH | Hoth Therapeutics, Inc. | $5.90M |
| RNAZ | TransCode Therapeutics, Inc. | $5.88M |
| NUWE | Nuwellis, Inc. | $5.86M |
| BNOX | Bionomics Limited | $5.83M |
| PPBT | Purple Biotech Ltd | $5.81M |
| SBFM | Sunshine Biopharma, Inc. | $5.78M |
| QNTM | Quantum BioPharma Ltd. | $5.54M |
| CMND | Clearmind Medicine Inc. | $5.39M |
| ONCO | Onconetix, Inc. | $5.32M |
| CSCI | COSCIENS Biopharma Inc. | $5.11M |
| BMRA | Biomerica, Inc. | $5.05M |
| ADTX | Aditxt, Inc. | $5.01M |
| ALZN | Alzamend Neuro, Inc. | $4.78M |
| APVO | Aptevo Therapeutics Inc. | $4.60M |
| ALBT | Avalon GloboCare Corp. | $4.58M |
| ALLR | Allarity Therapeutics, Inc. | $4.52M |
| SXTP | 60 Degrees Pharmaceuticals, Inc. | $4.48M |
| HEPA | Hepion Pharmaceuticals, Inc. | $4.38M |
| SLXN | Silexion Therapeutics Corp | $4.36M |
| PCSA | Processa Pharmaceuticals, Inc. | $4.35M |
| TNFA | TNF Pharmaceuticals, Inc. | $4.33M |
| ATNF | 180 Life Sciences Corp. | $4.29M |
| LIXT | Lixte Biotechnology Holdings, Inc. | $4.14M |
| NIVF | NewGenIvf Group Limited | $3.97M |
| SNPX | Synaptogenix, Inc. | $3.90M |
| APM | Aptorum Group Limited | $3.90M |
| SNOA | Sonoma Pharmaceuticals, Inc. | $3.84M |
| ISPC | iSpecimen Inc. | $3.82M |
| XRTX | XORTX Therapeutics Inc. | $3.82M |
| PTIX | Protagenic Therapeutics, Inc. | $3.74M |
| KTTA | Pasithea Therapeutics Corp. | $3.72M |
| DWTX | Dogwood Therapeutics, Inc. | $3.65M |
| ATXI | Avenue Therapeutics, Inc. | $3.63M |
| LIPO | Lipella Pharmaceuticals Inc. | $3.61M |
| PTPI | Petros Pharmaceuticals, Inc. | $3.60M |
| ARTL | Artelo Biosciences, Inc. | $3.58M |
| ENVB | Enveric Biosciences, Inc. | $3.58M |
| APTO | Aptose Biosciences Inc. | $3.43M |
| INM | InMed Pharmaceuticals Inc. | $3.41M |
| TCRT | Alaunos Therapeutics, Inc. | $3.38M |
| WINT | Windtree Therapeutics, Inc. | $3.33M |
| TTNP | Titan Pharmaceuticals, Inc. | $3.32M |
| THAR | Tharimmune, Inc. | $3.22M |
| BPTH | Bio-Path Holdings, Inc. | $3.19M |
| QLGN | Qualigen Therapeutics, Inc. | $3.15M |
| ENTO | Entero Therapeutics, Inc. | $3.10M |
| PHIO | Phio Pharmaceuticals Corp. | $2.97M |
| MTEM | Molecular Templates, Inc. | $2.96M |
| SCNI | Scinai Immunotherapeutics Ltd. | $2.89M |
| NCNA | NuCana plc | $2.88M |
| DRMA | Dermata Therapeutics, Inc. | $2.80M |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $2.75M |
| BDRX | Biodexa Pharmaceuticals Plc | $2.72M |
| ZVSA | ZyVersa Therapeutics, Inc. | $2.67M |
| NDRA | ENDRA Life Sciences Inc. | $2.66M |
| CTOR | Citius Oncology, Inc. | $2.59M |
| BIOR | Biora Therapeutics, Inc. | $2.53M |
| CYCC | Cyclacel Pharmaceuticals, Inc. | $2.41M |
| SLRX | Salarius Pharmaceuticals, Inc. | $2.33M |
| NLSP | NLS Pharmaceutics AG | $2.32M |
| HSDT | Helius Medical Technologies, Inc. | $2.20M |
| TIVC | Tivic Health Systems, Inc. | $2.07M |
| GLMD | Galmed Pharmaceuticals Ltd. | $1.96M |
| REVB | Revelation Biosciences, Inc. | $1.93M |
| PALI | Palisade Bio, Inc. | $1.91M |
| UPC | Universe Pharmaceuticals INC | $1.83M |
| PBM | Psyence Biomedical Ltd. | $1.75M |
| PRFX | PainReform Ltd. | $1.67M |
| VRPX | Virpax Pharmaceuticals, Inc. | $1.52M |
| SXTC | China SXT Pharmaceuticals, Inc. | $1.49M |
| CYTO | Altamira Therapeutics Ltd. | $1.49M |
| TFFP | TFF Pharmaceuticals, Inc. | $1.34M |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | $1.29M |
| SPRC | SciSparc Ltd. | $741.35K |
| TCBP | TC Biopharm (Holdings) Plc | $339.38K |